Recent News

By Category: Research

Soligenix Demonstrates Robust Stability Results with its SGX204 Anthrax Vaccine

(Sacramento Bee) SGX204 is a hyperimmunogenic derivative of PA and is being developed as a vaccine to protect against anthrax disease either as a pre-exposure prophylactic vaccine or post-exposure vaccine. Positive stability was demonstrated when DNI rPA was subjected …

January 19, 2012
| Filed under North America, Countermeasures, and Research
Share

Killer flu creators lash out at US ‘censorship’

(RT) Fouchier initially wanted to publish his research so as to prepare humanity for a potential outbreak of the artificially-made virus, but the US National Science Advisory Board for Biosecurity (NSABB) got involved and asked him to withhold some …

January 18, 2012
| Filed under Asia/Pacific, Europe, North America, Agents & Toxins, International, Policy & Initiatives, and Research
Share

Paragon Bioservices Awarded Multi-Million Dollar DoD Contract for Filovirus …

(Sacramento Bee) There are currently no licensed vaccines or treatments against filoviruses, even though there is up to a 90% fatality rate in humans, which makes them a potential agent of bioterrorism. Paragon will develop a large-scale mammalian process that is …

January 18, 2012
| Filed under North America, Agents & Toxins, Countermeasures, and Research
Share

Sword and Shield: The Dual Uses of Pathogen Research

(Science Progress) Jonathan Moreno weighs in on the wisdom of scientists publishing data from studies that create deadly viruses in his recent posting “Bird Flu Blues.” As he asserts, some of the hardest questions in the process of scientific discovery aren’t about science, but philosophy. Is it wise, from what we know now, for scientists Read More »

January 18, 2012
| Filed under Europe, North America, Policy & Initiatives, Public Health, and Research
Share

WHO will take a role in solving issued raised by bird flu studies controversy

(Winnipeg Free Press) The World Health Organization says it will take a role in helping the scientific and biosecurity communities sort through a controversy over the US government blocking full publication of two bird flu studies….